The Effect of Age and Other Patient Characteristics on Outcomes Among Nontransplanted Patients Who Were Treated With First-Line Lenalidomide, Bortezomib, and Dexamethasone: Results From the ConnectⓇ MM Registry
Year: 2024
Type: article
Institutions: Indiana University Hospital, Indiana University Indianapolis, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis, The University of Texas MD Anderson Cancer Center, Rocky Mountain Cancer Centers, Mayo Clinic in Florida, University of South Carolina, Maryland Oncology Hematology, Somerville Hospital, Duke Medical Center, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Bristol-Myers Squibb (Switzerland), Bristol-Myers Squibb (United States), Mount Sinai Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4399294979